Peptide Sciences Review 2026: Market Growth, Clinical Data, and Product Comparison Guide
Peptide Sciences Review 2026: Market Growth, Clinical Data, and Product Comparison Guide The 2026 peptide market is projected to exceed $50 billion, driven by anti-aging and metabolic applications. This review analyzes leading brands (e.g., Peptide Sciences, Limitless Life) against clinical data, comparing purity (>98% HPLC), lyophilized vs. liquid forms, and GMP-certified facilities. Key differentiators include third-party testing (COA), reconstitution protocols, and logistics (cold-chain compliance). Brands with ISO 9001 and FDA-registered facilities demonstrate superior stability. Selection criteria prioritize batch-specific certificates, peptide type (e.g., GHK-Cu vs. BPC-157), and research-grade purity. Industry trends show rising demand for custom synthesis and sterile filtration, underscoring the need for verified supplier credentials.